Home > National Drug Code (NDC) > Montelukast Sodium

Montelukast Sodium - 55111-763-03 - (Montelukast Sodium)

Alphabetical Index


Drug Information of Montelukast Sodium

Product NDC: 55111-763
Proprietary Name: Montelukast Sodium
Non Proprietary Name: Montelukast Sodium
Active Ingredient(s): 4    mg/1 & nbsp;   Montelukast Sodium
Administration Route(s): ORAL
Dosage Form(s): GRANULE
Coding System: National Drug Codes(NDC)

Labeler Information of Montelukast Sodium

Product NDC: 55111-763
Labeler Name: Dr.Reddy's Laboratories Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202906
Marketing Category: ANDA
Start Marketing Date: 20120920

Package Information of Montelukast Sodium

Package NDC: 55111-763-03
Package Description: 30 PACKET in 1 CARTON (55111-763-03) > 500 GRANULE in 1 PACKET (55111-763-07)

NDC Information of Montelukast Sodium

NDC Code 55111-763-03
Proprietary Name Montelukast Sodium
Package Description 30 PACKET in 1 CARTON (55111-763-03) > 500 GRANULE in 1 PACKET (55111-763-07)
Product NDC 55111-763
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Montelukast Sodium
Dosage Form Name GRANULE
Route Name ORAL
Start Marketing Date 20120920
Marketing Category Name ANDA
Labeler Name Dr.Reddy's Laboratories Limited
Substance Name MONTELUKAST SODIUM
Strength Number 4
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of Montelukast Sodium


General Information